Clearmind Medicine Inc. (Nasdaq: CMND) announced an exclusive licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. Clearmind said it will get exclusive worldwide rights to develop, research, manufacture, market, and commercialize products derived from a patent-pending synthesis of psychedelic compounds. This company said in a …
Category: Psychedelics
Congressional cannabis & psychedelics votes (Newsletter: April 17, 2024)
Nevada regulators will hold a workshop on changes to cannabis testing laboratory rules on April 30. — Marijuana Moment is tracking more than 1,400 …
Congressional Lawmakers Approve GOP-Led Marijuana And Psychedelics Bills Focused …
… Nevada’s First Marijuana Consumption Lounge … medical marijuana. The requests from groups … medical marijuana research. In October, VA …
Going concern warnings cloud Xtacy Therapeutics’ shrunk losses
Canadian-based Xtacy Therapeutics Corp. (CSE: XTCY) (OTCQB: XTCYF), formerly known as Global Wellness Strategies Inc., posted financials for the fiscal years ending Sept. 30, 2023, and 2022, showing an uphill battle to keep its doors open. The company, which operates as a merchant bank focused on the wellness and biotech …